In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).

Meeting to be held in Denver on March 10 hosted by Craig-Hallum. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

CarParts.com (NASDAQ: PRTS), a leading eCommerce destination for automotive parts and accessories, today announced that it is ...

Docebo (NASDAQ:DCBO – Get Free Report) had its target price lowered by research analysts at Scotiabank from $55.00 to $45.00 ...

New York State Common Retirement Fund purchased a new stake in Silvaco Group, Inc. (NASDAQ:SVCO – Free Report) in the 4th ...

Overall, analysts have set a median price target of $12 per share, which would be a 27% increase. Even the low end of the range, $11 per share, suggests a 17% stock price increase.

Fintel reports that on February 28, 2025, Craig-Hallum initiated coverage of MediWound (NasdaqGM:MDWD) with a Buy ...

We recently compiled a list of the 10 Worst Performing IT Services Stocks to Buy According to Analysts. In this article, we are going to take a look at where TechTarget, Inc.

CarParts.com (NASDAQ: PRTS), a leading eCommerce destination for automotive parts and accessories, today announced ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55 ...